C FIN INT INV unveils 5-for-1 share consolidation, HK$87.77 million placement and HK$12.51 million warrant package

Bulletin Express05-11 18:03

China Financial International Investments Limited (C FIN INT INV, 00721) has issued a circular outlining five key proposals to be voted on at a special general meeting (SGM) scheduled for 29 May 2026.

Key transactions

1. Five-into-one share consolidation • Every five HK$0.01 share will be consolidated into one HK$0.05 share effective 2 June 2026. • Issued share capital will contract from 10.97 billion to 2.19 billion shares; authorised capital remains HK$300 million. • Board lot size stays at 10,000 shares; fractions will be aggregated and sold for the Company’s benefit. • Parallel trading of old and new certificates runs 16 June – 8 July 2026; free exchange of certificates ends 10 July 2026.

2. HK$87.77 million share subscription under specific mandate • Subscriber: Phancy International Ltd, a wholly-owned unit of Phancy Group (HKEX: 6682). • Volume: 2.19 billion existing shares (438.87 million consolidated shares), equal to 16.67% of enlarged share capital. • Price: HK$0.04 per existing share (HK$0.20 per consolidated share), a 31.03% discount to the 7 May 2026 close. • Net proceeds: about HK$87.27 million. • Closing expected by 12 June 2026, subject to shareholder and regulatory approvals.

3. Issue of 2.50 billion unlisted warrants (500.31 million post-consolidation) • Warrants carry a two-year life and an initial exercise price of HK$0.058 per existing share (HK$0.29 per consolidated share), adjustable under standard mechanisms. • Issue price: HK$0.005 per warrant (HK$0.025 post-consolidation). • Subscribers and allocations: – Phancy International Ltd: 1.60 billion warrants (HK$8.01 million issue proceeds; HK$92.89 million potential exercise proceeds). – Mr Huang Shiying (18.23% shareholder): 0.60 billion warrants (HK$3.00 million; HK$34.80 million). – Mr Liu Yongxing (associate of Mr Huang): 0.30 billion warrants (HK$1.50 million; HK$17.40 million). • Aggregate immediate proceeds: HK$12.51 million; additional HK$145.09 million if all warrants are exercised. • Exercise is conditional on each holder (or designated investors) making a “Minimum Investment” in C FIN INT INV before the second anniversary (HK$1.92 million, HK$0.72 million and HK$0.36 million for Subscribers I, II and III respectively), plus compliance with Takeovers Code and 25% public-float requirement.

4. Use of proceeds • First-tranche net proceeds of approximately HK$98.78 million (subscription plus warrant issue) will be deployed 85% to new financial-asset investments and 15% to general working capital. • Second-tranche net proceeds of about HK$145.00 million from full warrant exercise will be applied on the same basis.

5. Governance and approvals • Independent Financial Adviser: Nuada Limited; Independent Board Committee recommends voting in favour. • Warrant Subscriber II and his associates (18.23% shareholding) must abstain from voting on connected-transaction resolutions. • All resolutions will be decided by poll; register closes 26 – 29 May 2026.

Key dates (Hong Kong time) • Last day to transfer shares for SGM: 22 May 2026. • SGM: 29 May 2026. • Consolidation effective: 2 June 2026. • Parallel trading: 16 June – 8 July 2026.

The proposed capital restructuring, fundraising and warrant arrangements aim to broaden the shareholder base, provide up to HK$243.87 million in new capital (combined immediate and potential proceeds) and align the Company with its growth and investment plans. Shareholders will vote on all proposals at the forthcoming SGM.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment